Monopar Therapeutics (MNPR) Non-Current Debt (2020)
Monopar Therapeutics (MNPR) has disclosed Non-Current Debt for 1 consecutive years, with $54628.0 as the latest value for Q3 2020.
Monopar Therapeutics (MNPR) has disclosed Non-Current Debt for 1 consecutive years, with $54628.0 as the latest value for Q3 2020.